M-tron Industries designs and manufactures frequency and spectrum control products such as radio frequency and microwave filters, crystal oscillators, and resonators for aerospace, defense, space, and avionics markets. As a small-cap name, it has limited sell-side coverage, and I identified only two current, attributable targets. Freedom Capital Markets analyst Sergey Glinyanov holds an $81 target after downgrading to Hold from Buy in May 2026 while raising it from $78. Sidoti & Company analyst Anja Soderstrom maintains a $90 target, raised from $87 in August 2026 and based on a 35x multiple to a 2027 EPS estimate of $2.54. The arithmetic mean of these targets is $85.50, which I round to $85 here, with a range of $81 to $90. Both analysts rate the stock Hold, reflecting a view that long-term growth potential is partly offset by valuation and timing uncertainty. This is not an official consensus, so with just two data points the average serves as a directional reference rather than a precise forecast. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
At the latest verified close of $63.95, MPTI trades roughly 39% below its 52-week high of $104.85 and above its 52-week low of $43.55. The stock carries a market capitalization near $278 million, a trailing P/E ratio of about 25, and trailing-twelve-month revenue of $58.2 million with net income of $9.52 million. Reaching $85 from $63.95 requires approximately a 33% advance — a substantial move for a micro-cap name. The path would likely depend on sustained revenue growth, margin recovery, and evidence that defense and space programs are converting backlog into shipments. Notably, the entire $81–$90 analyst range still sits below the stock's prior high, underscoring how much the shares have de-rated since mid-2026.
The shares sit in the lower-middle portion of a $43.55–$104.85 52-week range, having fallen sharply from the summer 2026 peak near $85–$98 to the low $60s. The $81–$90 target zone coincides with a region the stock traded through earlier in 2026, which could act as an area of overhead supply. The prior 52-week high near $105 remains a longer-term reference point well above current analyst targets. From what I see, this setup suggests overhead resistance may need to be cleared before any sustained advance.
Analyst price targets generally reflect a research horizon of about 12 months, though the actual horizon is not always stated. Investors should watch the Q3 2026 earnings report scheduled for November 12, 2026, where consensus estimates call for roughly $0.59 in EPS on about $15.30 million in revenue, as well as guidance, backlog growth, margin trends, the pace of missile-program ramp-up, and any analyst target revisions. I’m watching this closely as these data points will likely determine whether the recovery narrative gains traction.
The $85 central target — the mean of two current analyst targets ($81 and $90) — implies a substantial 33% advance from the $63.95 close. Support comes from record revenue, a growing backlog, and a debt-free balance sheet, while the principal obstacles are margin compression, shareholder dilution, and delayed missile-program contributions. With only two Hold-rated analysts and the stock trading well below its 52-week high, the target represents a plausible recovery scenario rather than a near-term certainty, making upcoming earnings and backlog data the key signposts to watch.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile small-cap like MPTI, these signals can help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual review. I find this tool useful when cross-checking my own analysis on names with limited coverage.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MPTI's RSI Indicator exited the oversold zone, 14 of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +11.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where MPTI advanced for three days, in 193 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
MPTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MPTI as a result. In 52 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for MPTI turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 28 similar instances when the indicator turned negative. In 20 of the 28 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
The 50-day moving average for MPTI moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MPTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for MPTI entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.209) is normal, around the industry mean (3.856). P/E Ratio (20.845) is within average values for comparable stocks, (6.228). Projected Growth (PEG Ratio) (1.170) is also within normal values, averaging (0.930). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (4.968) is also within normal values, averaging (4.422).
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. MPTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MPTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ElectronicComponents